Paradoxical Relationship Between B-type Natriuretic Peptide and Pulmonary Vascular Resistance in Patients with Ventricular Septal Defect and Concomitant Severe Pulmonary Hypertension

被引:0
作者
Manatomo Toyono
Kenji Harada
Masamichi Tamura
Mieko Aoki-Okazaki
Shunsuke Shimada
Jun Oyamada
Goro Takada
机构
[1] Akita University,Pediatrics, Reproductive and Developmental Medicine
[2] Harada Kid’s Clinic,undefined
来源
Pediatric Cardiology | 2008年 / 29卷
关键词
Ventricular septal defect; B-type natriuretic peptides; Pulmonary hypertension;
D O I
暂无
中图分类号
学科分类号
摘要
B-type natriuretic peptide (BNP) reflects volume overload on left ventricle and pulmonary hypertension (PH) in patients with ventricular septal defect (VSD). Pulmonary vascular resistance (PVR) has been reported to correlate positively with BNP in VSD patients with various degrees of PH. We aimed to investigate the relationship between PVR and BNP in VSD patients with severe PH. We examined 24 subjects with VSD concomitant severe PH aged from 2 months to 17 years (median: 4 months). The ratio of pulmonary to systemic pressure (Pp/Ps), the ratio of pulmonary to systemic flow (Qp/Qs), the ratio of pulmonary to systemic resistance (Rp/Rs), and PVR were determined by cardiac catheterization. PVR and Rp/Rs ranged from 1.6 to 15.5 (mean: 5.7 ± 3.9) Wood unit · m2 and 0.1 to 0.8 (mean: 0.4 ± 0.2), respectively. BNP ranged from 5.5 to 69 (mean: 31 ± 19) pg/ml. Negative correlations were observed between BNP and PVR (r = -0.56, p = 0.004) and BNP and Rp/Rs (r = -0.51, p = 0.01). BNP was significantly lower (<10 pg/ml) in VSD patients with Eisenmenger physiology as compared with the others (p = 0.003). We should draw attention to evaluate BNP values in VSD patients with severe PH.
引用
收藏
页码:65 / 69
页数:4
相关论文
共 92 条
  • [1] Chang AC(1993)Real-time gas-exchange measurement of oxygen consumption in neonates and infants after cardiac surgery Crit Care Med 21 1369-1375
  • [2] Kulik TJ(2001)Left ventricular remodelling and brain natriuretic peptide after first myocardial infarction Heart 86 638-642
  • [3] Hickey PR(2005)B-type natriuretic peptide in organic mitral regurgitation: determinants and impact on outcome Circulation 111 2391-2397
  • [4] Wessel DL(2006)Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation Am J Cardiol 97 1029-1034
  • [5] Crilley JG(1981)Use of relative operating characteristic analysis in epidemiology A method for dealing with subjective judgement. Am J Epidemiol 114 649-662
  • [6] Farrer M(2005)Brain natriuretic peptide: diagnostic and therapeutic implications in pulmonary arterial hypertension Semin Respir Crit Care Med 26 385-393
  • [7] Detaint D(1986)Variability of right-sided cardiac oxygen saturations in adults with and without left-to-right intracardiac shunting Am J Cardiol 58 129-132
  • [8] Messika-Zeitoun D(2005)Serial changes in plasma brain natriuretic peptide concentration at the infarct and non-infarct sites in patients with left ventricular remodelling after myocardial infarction Heart 91 1573-1577
  • [9] Avierinos JF(2005)The value of B-type natriuretic peptide and big endothelin-1 for detection of severe pulmonary hypertension in heart transplant candidates Eur J Heart Fail 7 1149-1155
  • [10] Detaint D(1970)The estimation of oxygen consumption Cardiovasc Res 4 23-30